Study #2015-0586
Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors
MD Anderson Study Status
Enrolling
Treatment Agent
Bevacizumab
Description
This pilot clinical trial studies the side effects and best dose of radiation therapy in patients with brain tumors that have come back after previous treatment with radiation therapy. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radiation therapy in different ways may kill more tumor cells.
Information and next steps
Disease:
Recurrent Brain Neoplasm
Study phase:
Not applicable
Physician name:
Susan McGovern
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help us #endcancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.